Teva Pharmaceutical Industries Limited (TEVA) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

Key Points Company and Industry Overview 1. Company: Teva Pharmaceutical Industries Limited (NYSE:TEVA) 2. Event: 43rd Annual J.P. Morgan Healthcare Conference 3. Date: January 13, 2025 4. Time: 11:15 AM ET 5. Participants: - Richard Francis - President and CEO - Eric Hughes - Head of R&D and Chief Medical Officer - Chris Schott - J.P. Morgan [2] Company Performance and Strategy 1. Richard Francis' Background: Joined Teva about two years ago 2. Teva's Transformation: Focused on the Pivot to Growth strategy, driving significant change within the company 3. Teva's Status: Global, profitable biopharmaceutical company 4. Innovative Business: Growing and exciting innovative business segments, including AUSTEDO, AJOVY, and UZEDY [3][5]